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Abstract
Two years after the introduction of free antiretroviral therapy (ART) in Tanzania and in spite of the
logistical support provided to facilitate clinic attendance, a considerable level of attrition from the
program was identified among clients from a semi-rural ward. Qualitative research on ART patients’
health-seeking behavior identified factors affecting sustained attendance at treatment clinics. A mix
of methods was used for data collection including semi-structured interviews with 42 clients and 11
service providers and 4 participatory group activities conducted with members of a post-test group
between October and December 2006. A socio-ecological framework guided data analysis to
categorize facilitators and barriers into individual, social, programmatic, and structural level
influences, and subsequently explored their interaction and relative significance in shaping ART
clients’ behavior. Our findings suggest that personal motivation and self-efficacy contribute to
program retention, and are affected by other individual-level experiences such as perceived health
benefits or disease severity. However, these determinants are influenced by others’ opinions and
beliefs in the community, and constrained by programmatic and structural barriers. Individuals can
develop the requisite willingness to sustain strict treatment requirements in a challenging context,
but are more likely to do so within supportive family and community environments. Effectiveness
and sustainability of ART roll-out could be strengthened by strategic intervention at different levels,
with particular attention to community-level factors such as social networks’ influence and support.
Introduction
Despite the international health community’s initial concerns over whether antiretroviral
therapy (ART) programs could be feasibly introduced within the widespread poverty of much
of sub-Saharan Africa, treatment compliance in the region has sometimes exceeded rates found
in richer countries.1-3 Notwithstanding that, adherence to ART in Africa is often poor and there
are fears it could decrease over time.4 A recent meta-analysis covering 13 African countries
suggests that approximately 40% of all ART clients might have died or discontinued treatment
within 2 years of having initiated it.5 Sustaining life-long treatment might be particularly
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challenging for rural residents who need to travel regularly to major hospitals to obtain pill
refills and undergo follow-up checks.
In Kisesa, a semi-rural ward of North Tanzania, a longitudinal surveillance and monitoring
project (TAZAMA) is documenting the implementation of the national ART program,
including its clinical impact and broader epidemiologic, demographic, and socioeconomic
outcomes. As ART is being scaled-up, a parallel process of research is mapping ongoing
community-level responses in order to identify emerging problems and inform the timely
development of policy recommendations. At the onset of ART roll-out, formative research was
conducted to identify and mitigate perceived and experienced barriers to treatment initiation
among Kisesa residents.6 This early community-based research identified concerns over
sustaining long-term treatment, transportation costs, and the referral hospital’s reputation for
being unfriendly as key factors hampering accessibility to the Care and Treatment Clinic
(CTC). A series of measures were consequently introduced by the program to alleviate practical
and financial barriers, including the provisions of a fare to cover transportation costs and an
“escort” from a community-based organization who accompanied clients during their first visit
to the clinic. Furthermore, two nurses were hired at the CTC specifically to “meet and greet”
Kisesa referrals and assist with clinical assessments and subsequent visits. These measures
facilitated registration procedures and relieved anxiety related to attending the clinic for the
first time. However, in spite of the support provided, a considerable level of attrition from the
program was identified among clients from this ward at a 2-year follow-up.
The observational cohort study in which this research is nested offers an opportunity to track
how ART provision has moved from a “pilot” phase in which we were able to identify how
barriers to treatment initiation could be overcome on a small scale through resource-intensive
interventions, to a scaled-up version where we can longitudinally assess longer term challenges
faced by national ART programs.
Theoretical Framework
This study applied a social-ecological framework to the exploration of barriers and facilitators
to sustained treatment adherence experienced by ART patients. Social-ecological theories
situate individuals in a dynamic “social ecology”7 in which individuals adapt their behavior to
their social environment and take decisions based on information, influence, and interactions
available through local social networks, relationships, and institutions. At the same time, social
structures and processes are shaped by the collective behavior of individuals, which can shift
over time.8 Social ecological approaches eschew polarized debates between proponents of
“individualist” versus “structuralist” models and instead argue that health promotion requires
interventions at both levels, and that they represent two ends of a continuum rather than
dualistic opposites.9
Drawing on formative research conducted in the same setting6 and the growing body of
literature on ART programs in developing countries, the following social-ecological
framework (Fig. 1) illustrates the factors underpinning treatment adherence at individual,
community, programmatic and structural levels. The framework builds on existing theories to
illustrate possible interactions between contextual and individual determinants and the
pathways through which these affect health-seeking behavior. Data collection was
subsequently guided by these categories in order to understand their relative importance and
specific manifestations in the study setting.
Theories that have focused on the individual’s behavioral decision-making consider how
people determine whether they will engage in certain behavior.10,11 This process requires
careful balancing of perceived benefits against constraints of adopting a particular course of
action, and does not occur in a vacuum but rather reflects the availability of useful or accurate
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information and the wider social environment, including prevalent norms and the extent and
supportiveness of social networks.8,9 Numerous studies have confirmed that the level of
support received from family members and close social networks strongly influences individual
behaviors and decisions regarding treatment.12-15 A South African study, for instance, found
that receiving social support was instrumental in helping ART patients achieve compliance
beyond the first 3 months of treatment.16
Program-level factors will also shape individuals’ cost-benefit analysis of seeking and
sustaining treatment. The distance to medical services, financial and opportunity costs of travel,
and quality of care such as waiting time, attitude of providers, and ease of following instructions
for complex regimens have all been identified as determinants of treatment compliance.6,
16-18 For example, in a study conducted in Uganda, Tanzania, and Botswana, the costs related
to ART clinic attendance and long waiting times were identified as major obstacles to treatment
adherence.19
Individuals thus formulate personal opinions and behavioural intentions while negotiating their
social environment and the parameters of the ART program, and they do so against a broader
structural background that, in much of sub-Saharan Africa, includes entrenched poverty, food
insecurity, weakened health systems, and a lack of formalized social welfare mechanisms. One
outcome of the interaction of all these social influences is individuals’ self-efficacy—
confidence in being able to act on one’s decisions—that in the case of ART relates to the ability
to identify a feasible treatment plan and remain compliant to it by persevering in the face of
obstacles and integrating it into day-to-day routines.20 Evidence from several studies supports
the central role played by self-efficacy in sustained treatment, as it has been found to be
associated with decreased likelihood of missing scheduled appointments20 and higher levels
of drug adherence.21-25
Methods
Part of a wider community-based cohort study monitoring Tanzania’s ART roll-out, this study
used a qualitative approach to investigate the diversity and interplay of factors underlying
attendance at ART clinics. A mix of methods was used including semi-structured interviews
with 42 clients and 11 service providers and 4 participatory group activities conducted with
members of a post-test group during routine monthly meetings. Research activities were
recorded with permission, transcribed, and translated into English. Details on the study
setting26 have been provided elsewhere. Ethical approval for the research was obtained from
both the LSHTM Ethical Committee and the Tanzanian National Ethical Research Board.
Data were analyzed with the qualitative software package NVIVO-7 using the social-ecological
framework as an initial coding guide, followed by detailed thematic content analysis to refine
subthemes, make comparisons between cases, and identify contradictions and outliers.
Relationship codes were created to analyze links between categories and respondents were
classified by demographic variables to explore patterns by gender, residence, and age. Findings
were triangulated through comparison across study participants as well as data collection
method. Two researchers independently coded data and discussed emerging hypotheses, which
were subsequently tested by rereading transcripts and fine-tuning the interpretation of coded
themes to maximize rigor.
Results
Individual factors
In line with individual-level behavioral theories, perceptions of disease severity and
susceptibility, as well as perceived benefits and barriers of staying on treatment, emerged as
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key determinants of clinic attendance. These were manifested as two primary psychological
constructs: personal willingness (motivation) and perceived capacity (self-efficacy).
Most study participants reported having experienced positive physiologic outcomes from
treatment, and this tended to increase motivation to stay on ART. Motivated patients trusted
antiretroviral drugs, felt a sense of personal responsibility over their treatment, and perceived
themselves to be capable of meeting its requirements despite difficulties encountered:
Because these drugs are giving me hope so that I may live, I have only to drag myself
although it is far. (female, roadside area)
Even if you get a problem today, you will go there the following day and continue
with the drugs because that medicine is your life. (Group activity, males from remote
areas)
While some barriers to treatment were seen as beyond personal control, patients emphasized
the need for individual persistence in the face of obstacles.
The obstacle is that, maybe when you are very sick, you can’t even walk. To come to
the road, to go to the bus stand (...). You arrive there and you stay for a long time. I
mean you are hungry and sick (...) at four o’clock you are just still there. Then it is
far from here, I mean we get problems, but as you are in search for life, you have only
to persevere. (female, roadside area)
However, among clients who were not experiencing physical recovery, “losing hope” could
lead to attrition from the program. As mentioned by a group of men brainstorming about a
typical community member on ART:
He is ignoring these drugs. Maybe he has used them without any good results, and
hence he decided to quit using them completely. Our friend wanted to get better
immediately ... (Group activity, males from remote areas)
Regaining health does not automatically lead to strengthened motivation, as in some cases it
was interpreted as a sign of declining HIV severity, reducing a patient’s commitment to
treatment adherence or leading to interrupted treatment:
... she was in a bad condition, she has used these drugs and her condition became
well ... she felt that she was cured, hence there was no need of going to the clinic. It
will make her think that she is well, she is just healthy and sound, she doesn’t feel
any pain, and from there she will see those things as useless. (Group activity, females
from remote areas)
Social factors
At the community level, the study examined how social norms and support from personal
networks affected treatment patterns. First, it emerged that prevailing beliefs around the causes
and basic etiology of HIV could reduce motivation for biomedical treatment. Beliefs that HIV
is caused by witchcraft, and that it can be cured through spiritual healing and/or traditional
medicine are common in Kisesa and other semirural communities in sub-Saharan Africa27,28
and can weaken confidence in ART effectiveness:
God is really able, He can really heal even AIDS. There were rashes on my face but
the bishop laid his hands upon me and said that these rashes will disappear, and really
after one day, I woke up in the morning of the following day and those rashes had
disappeared completely. I think it was just the power of that faith in God that this
problem is finished. (male, roadside area)
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S/he thinks that Jesus has healed him/her and won’t attend clinic again. (home-based
care provider)
I checked the chest and they said it was okay, this one is bewitched .... there is medicine
sold in Arusha. It’s called “Ngetwa” ... For HIV ... They said it’s traditional, it’s
obtained from the Masai in Arusha ... Ngetwa, people used to talk ... perhaps if we
assist this person with Masai medicines, because he is tired of injections .... they said
let’s go now to Arusha. (male, roadside area)
Misconceptions and rumors related to the antiretroviral drugs themselves also generate mistrust
and confusion, negatively influencing the motivation for initiating therapy among potential
patients, as well as contributing to treatment interruption among those already enrolled in the
program:
Those drugs make them ... They cut, they really cut ... I mean people are just dying.
You just find yourself dying. You die while you are just fat. That is just the belief.
(female, roadside area)
Those medicines were so confusing. Sometimes you hear that if you use those
medicines you will die. So it used to confuse people so much ... we used to fear it so
much that it means if you take these medicines you may die. (male, roadside area)
In some cases, misunderstanding about the incompatability of certain behaviours with
treatment, such as drinking alcohol, smoking cigarettes, or engaging in sex, could dishearten
patients and lead to decreased levels of self-efficacy.
The other obstacle is that ... you actually go to the clinic, you start by being given the
conditions about those drugs and you have a husband at home. When you go to involve
your husband, the husband shuns away, you see, he doesn’t like. Now you start
thinking that, when I start taking those drugs, it means that I will be just destroying
them, you see, I will be using the drugs while at the same time I will be having sex
with my husband, therefore there is nothing that I will be doing, it is better by 20 times
that I do what? I quit ... (Group activity, females from roadside areas)
Concerning alcohol we were forbidden to take alcohol, if you are using alcohol you
should now stop, so perhaps if you break those conditions and take alcohol then those
medicines shall be ineffective. So you are not supposed to take alcohol, you are not
supposed to smoke cigarette. (male, roadside area)
You shouldn’t take those drugs while at the same time you continue with sexual
matters. (male, remote area)
She will first be hesitating ... should she continue with the drugs or should she continue
having sex? (Group activity, females from remote areas)
While ambivalence and apprehension toward ART were part of the social environment, a more
explicit influence on individuals’ decision-making came from the opinions of sexual partners,
family members, friends, and influential community members. Social networks created
powerful conduits for both support and discouragement vis-à-vis sustained treatment. Some
ART clients dropped out from the program even after having been provided with accurate
information at the health facilities when confronted with skepticism from influential peers:
The other thing is that, maybe you get a friend, then s/he starts telling you many things,
maybe about AIDS. Then you start thinking: so there isn’t even that need of going to
the clinic. That is also an obstacle ... You can get a friend who will start telling you a
lot of words ... for example, they may just cheat you that it is AIDS, very many are
being told that “you are just being cheated, they are just liars, just quit going to the
clinic, what are you going to do there? Just stay at home and maintain your condition.”
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There are many who are being told so, then actually someone does what? s/he just
stays at home. You can be tempted because we hear just many things (...) if they tell
her that this is not a disease to be treated at the hospital, it is a disease that can be
treated by traditional healers, then she will decide to go to the traditional healers ...
(Group activity, females from remote areas)
... but now our clients they understand. But when they return to the community ...
some people lie to them: “Ah those drugs are not good. If you take ART you will die
and so and so.” But when they come here we are trying to give them information about
it that this is not correct (...) some people there at the community, they don’t know
their serostatus so they are trying to give our clients some rumors which are not true.
(ART clinic staff)
Similarly, other people’s positive perception about ART and in particular the opinions of those
already on therapy, influenced individuals’ decisions to test and stay on treatment.
There is a neighbor who told me that had been using them for a long period. Therefore
he also told me that I should also go there to check my health. She took me there. I
told her let’s go ... I started using these drugs and until now I am continuing using
them. (female, roadside area)
Because of my health, I have taken four guys to the VCT center. I tell them “just go
and check, sometimes you may think that it’s witches, but actually you are bewitching
yourself” (...) they go ... they have started (ART). (male, road-side area)
The experience of directly observing improved health among other ART patients within one’s
social network also positively influenced attitudes to treatment:
... when I saw my husband using them (ART) I decided to come to check too. (female,
remote area)
... other patients who used to hide themselves have seen their fellows who come to
these services are getting relief so they now turn up too. (ART clinic staff)
The level and source of interpersonal support, therefore, emerged as a significant catalyst for
self-efficacy and sustained motivation. Treatment supporters (selected by patients as a
prerequisite for enrollment in the national ART programme) and family members, including
children, were often reported to be important sources of hope and courage and to help
individuals integrate therapy into daily life by providing practical support such as reminding
of appointments, cooking, bringing medicines home, etc.
I was there with my sister. They kept on giving me courage ... At present I know I
can do everything, I am able. I just decided to choose them ... because in case I have
problems they can help me. (female, roadside area)
While I was still serious he used to come daily ... He would help me even to look at
my card. He would look at my return appointment date and say ‘ahaa, it’s not yet
due.’ So when the date approaches he comes to remind me: “don’t forget to go.” I
said “I won’t forget.” That’s how he was helping me, insisting to me: “the date is on
the card. You can’t forget it.” We kept reciting it: “it’s a certain date.” (male, remote
area)
... at home there is my child studying. If you have forgotten it (date of clinic
appointment) you just ask him/her: what is today’s date?’ S/he’ll say “it is a certain
date.” It’s not difficult; it’s just easy to me. (female, remote area)
It was that guy, that friend of mine ... he told me: “just continue taking the drugs, you
shouldn’t have any worries, you will be just cultivating without any problem.” (male,
roadside area)
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She can be advised, she gets someone to encourage her to continue using those drugs ...
Hope will come for one reason: she will get counseling. After getting counseling ...
she will be committed, she will understand and she will continue ... (Group activity,
females from remote areas)
Resource flows between network members serve as an important marker of social support in
a context of entrenched rural poverty, and the ability to obtain financial assistance from a family
member or close contact played a key role in individuals’ confidence that they could maintain
a treatment program:
You will struggle to get that money, you will even go to your relative to ask him/her
for money so that you may go to the clinic, you will go there and s/he will give you.
(female, roadside area)
In addition to family members, the level of support received by other CTC clients, post-test
club members and health professionals also emerged a factor contributing to retain clients in
the ART program.
When I arrived there the doctor told me, “ooh you have been infected with the
disease” ... after I received good instructions it encouraged me, I stopped worrying.
It’s when I got courage. (female, roadside area)
So we enlightened each other, we met those using it and they said “I used to be in a
very bad condition but right now I feel better, you come here walking so you are
better.” I was satisfied because if you go to clinic you meet your fellow there so you
exchange ideas. (male, roadside area).
While many study participants reported receiving family support, those that did not clearly
suffered negative outcomes in their physical and psychological well-being. Perceived lack of
family support led some individuals to drop-out from treatment altogether despite high levels
of personal motivations to continue and evidence of physical recovery. When family members
discouraged ART or suggested alternatives such as visiting religious preachers or traditional
healers, patients were reluctant to pursue a biomedical solution further. Some could not sustain
participation in the program without sufficient emotional or economic support:
Once you are segregated by your parents, where will you go? If you are being insulted
scolded at home you can’t go everyday to the clinic. (Group activity, females from
remote areas)
... there are others who are actually giving up hope, we see them even in their
families ... they don’t have people to help them. (female, roadside area)
I had asked father for some money in the morning and he told me that we are tired of
your diseases. (female, roadside area)
In extreme cases, the social influence of family members was so significant that relatives such
as parents or husbands actually made the choices regarding treatment, including taking the
decision to interrupt ART.
They tell him/her, aha, this disease has no cure so you are just wasting your time going
to hospital. S/he comes to tell you again that “I was told at home ... that I should not
go to hospital but I should go to church and I have answered them that I want to go
to hospital.” That’s a problem too ... sometimes he/she wants to go and check CD4
but you find that the family takes him/her to traditional healers ... They say “these
people just deceive you, you must be bewitched.” So when you return to that family
you find that s/he is not there ... Most of such people we get them from a family that
has got so many doubts so they have decided to take him/her to traditional healers.
(home-based care provider)
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You may find that perhaps a woman is forbiden by her husband. You might find that
a woman is ready to go there but her husband tells her “but I don’t have that disease
perhaps it’s you who has got it. And if you want to continue going there you should
leave my place,” so the woman stops to go there for her CD4 results and there is no
way of telling that woman to go for CD4 test again. (home-based care provider)
Maybe she may be having her partner at home who will prevent her, what are you
going to do there? (Group activity, females from remote areas)
On the positive side, however, local home-based care providers were able to step in and provide
a replacement social support network which contributed to client’s self-efficacy. In addition
to providing direct assistance with travel or subsistence, home-based care staff was described
by clients as providing a considerable level of encouragement both to ART patients themselves
and also to their affected families, helping increase empathy.
... we arrived to a place (ART clinic) ... that woman (home-based care provider) was
familiar with the place ... after getting that experience, I am now going alone. (male,
roadside area)
The attendants will be coming at home to visit from time to time ... they will go to
your parents and discuss with them and eventually it will come a stage when your
parents will understand. (Group activity, females from remote areas)
She was telling the people at home: ‘you shouldn’t segregate this person because she
is suffering from this and this, you should just be close to her’. Every time she was
going there at home until her relatives became close. (Group activity, females from
roadside areas)
Programmatic factors
The free provision of ART by the national Aids Control Program was mentioned as a factor
contributing to increased self-efficacy:
When I heard that the drugs were available and that were being given for free, honestly
I felt very pleased, I was very happy. That is why I wasn’t ashamed neither did I have
a grudge of continuing to receive the drugs. (female, roadside area)
On the other hand, the distance to the clinic regularly came up as a barrier to clinic attendance,
related to the inconvenience of travel, or the necessity of making the journey to the referral
hospital during severe illness:
I was carried on a bicycle by father, I was serious, I was wearing a gown, I tied myself
with a khanga, I was vomiting. After reaching the town I took a taxi to the clinic, after
arriving to the clinic I fell down. (female, roadside area)
Almost all study participants suggested, without any prompting, that the service should be
brought closer to the clients.
We would like the institutions to think of us, that they should build us hospitals nearby
here so that we could get medicine. (female, remote area)
Access to information during the “adherence training” sessions conducted as part of the
enrolment procedure seemed important to retention of clients. Mandatory participation of a
“treatment partner” in the program often proactively addressed some of the community-level
barriers, including skepticism and misconceptions about HIV and ART among family
members:
At the beginning I felt that even if I ... maybe I can talk and be stigmatized at home.
That is why I felt aah, it is better I just remain quiet. But when I started going to the
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clinic, when I attended classes, they knew everything, they were also educated, and
my mother too ... now all of them know that I go to the clinic in town, they know that
I have my clinic. (female, roadside area)
Structural factors
In the context of severe poverty of rural Tanzania, structural factors ultimately constrain
individuals’ ability to sustain treatment. Difficulties in procuring transport fares, conflicting
priorities on how to use any cash assistance provided through the programme, and inadequate
nutrition levels all emerged as factors leading to delayed or missed appointments.
During all the participatory group discussions, structural factors were consistently ranked as
posing the most intractable barriers to clinic attendance. Compared to these, social or
behavioral determinants were listed as of lesser importance and more easily resolved.
From that ranking they said unanimously that the biggest problems they face at the
time of going to the clinic are food and fare. Those are the leading obstacles that they
mentioned. They further added that the other obstacles are normal, and they can solve
them by working and collaborating with their relatives and friends. (notes from group
activity with males from roadside areas).
When considering what might lead a “typical ART client” to drop-out from the ART program,
study participants presented a clear analysis of how individual level facilitators, such as
“regaining health” could be stymied by barriers at the social level through lack of family support
or prevailing beliefs among relevant social networks that HIV could be cured through other
means. This tension played out against a backdrop of structural constraints, further mitigating
against successful achievement of individual behavioral intentions:
And when she goes to the clinic she uses her own ways, she goes to the clinic and she
gets those drugs, and when she brings them at home, she has to take them secretly.
Now she starts asking herself, “there is a day when I will be discovered here,” now
when she regains her health somehow, she thinks that she is cured, she decides to quit
taking the drugs. She actually quits. (Group activity, females from road-side areas)
Discussion
Many studies have focused on structural barriers to successful treatment compliance,
highlighting how inadequate nutrition, costly transport options, and the opportunity costs of
spending time seeking care pose insurmountable obstacles to many HIV-positive people in a
range of developing countries, including Tanzania.19,29-31 Such findings have led some to
suggest that structural, rather than behavioral, interventions may be the most useful to ensure
optimal treatment program.32
Our findings suggest, however, that while structural factors do significantly restrict individuals’
ability to comply with treatment, even when some of these barriers are alleviated (through free
provision of ART and transport costs) important challenges to sustained clinic attendance
persist. While removing structural obstacles is essential, addressing sociocultural and
psychosocial factors is also required.
Through the application of a social-ecological framework to piece together the multiplicity of
levels at which facilitators and barriers to health-seeking interact, our study demonstrates how
individuals adjust their behavior to their immediate social environment. The process through
which other’s people’s behaviors, advice, and beliefs determine health behavior (social
influence) emerges as a main pathway for individual decision-making and reflects localized
norms and levels of support within individuals’ social networks. The strength of social
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influence could act as a powerful motivator and strengthen an ART patient’s self-efficacy to
overcome other barriers, or could severely undermine capacity to follow through an intention
to remain on treatment, leading to dropping out from the program. This finding reinforces
similar results regarding the role of family and community social support on adherence from
a range of studies conducted in both developed and developing countries.33-36
As such, proactive efforts to engage with patients’ social networks could be a useful strategy
for improving retention rates. In highly family-centered, yet resource-poor, settings, social
capital assets are central to survival and thus families and other network members are likely
to play a much greater role in health-seeking decisions than in more individualistic societies
with solid institutional safety nets. Activities that already appear successful such as educating
and sensitizing family members through home based care workers could be expanded, as could
capitalizing on ART patients’ own ability to influence beliefs and social norms within their
social networks, and to offer referrals to the program as well as practical advice on overcoming
barriers to treatment.
At programmatic level, other possible implications from the research include experimenting
with community based ART distribution approaches to limit the physical exertion,
inconvenience, and financial and time costs of regular travel to the CTC clinic. In South Africa,
trials are underway of ART provision through community lay health workers (F.P. Lewin,
personal communication). It might also be worth taking a harm reduction approach to alcohol
and tobacco use rather than conveying strong disapproval during medical advice and training
sessions given by CTC staff in adherence training; similarly, acknowledging ART patients’
sexuality and local sexual norms may improve acceptability of risk reduction messages; these,
in turn, should take into consideration that most people on ART will neither wish nor be in a
position to give up regular sexual relations.
To conclude, individual psychosocial attributes, including motivation and self-efficacy, affect
sustained adherence to ART programs over a prolonged period of time, but are dependent on
the interaction of other determinants that operate at different levels. Using a social-ecological
framework to investigate and analyze the links and relative roles of individual, social,
programmatic and ultimately structural factors can help identify feasible “entry points” for
interventions to improve program retention and compliance in a specific context. Similar
approaches have been used in developing multi-level interventions for HIV prevention
programs, and this study demonstrates its useful application to seeking and sustaining ART.
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FIG. 1.
Factors and pathways influencing sustained clinic attendance among antiretroviral therapy
(ART) clients from a semi-rural area.
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